Consequently, we conclude that MB21D2 overexpression and its Q311E recurrent mutation play an important role in HNSCC by acting as an enrichment factor of KRAS‐mediated signaling along with PI3K‐AKT and CREB and EMT activation. This evidence concerns the gene KRAS and head and neck squamous cell carcinoma.